Equity Profile

PTCT

PTC Therapeutics, Inc.

Health CareBiotechnology$5.9B

Aug6Thu

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

PTC Therapeutics, Inc. is a biotechnology company focused on developing innovative medicines for rare diseases....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and will show how well PTC is managing its costs and revenues.

N/A

Revenue Growth

Revenue growth is crucial for assessing the company's ability to expand its market presence and sustain operations.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

PTCT Q2-2026 Earnings Preview

Context

Company Snapshot

PTC Therapeutics, Inc. is a biotechnology company focused on developing innovative medicines for rare diseases. With a market cap of $6 billion, it plays a significant role in the healthcare sector, particularly in addressing unmet medical needs through its advanced therapies.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+101.20%

Avg Stock Reaction

-1.79%

Last Quarter Recap

In Q1-2026, PTC reported an EPS of -$0.03, significantly beating expectations of -$0.45. However, the stock dropped 3.12% the following day, indicating mixed market reactions despite the positive surprise.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall expectations are cautious as PTC has shown a pattern of beating EPS estimates but experiencing stock price declines afterward. Investors will be closely watching for any signs of revenue growth and cost management.

Bull Case

If PTC can demonstrate strong revenue growth and continued improvement in EPS, it could signal a turnaround and attract more investor interest, potentially driving the stock higher.

Bear Case

If the company fails to meet revenue expectations or reports increased losses, it could lead to further declines in stock price, as investors may lose confidence in its growth prospects.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be this quarter, and how does it compare to previous quarters?

Given PTC's history of EPS surprises, this number will be critical in shaping investor sentiment and expectations.

What is the company's revenue growth compared to last quarter?

Revenue growth is essential for assessing the company's ability to sustain its operations and invest in future developments.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate PTC's ability to leverage its recent R&D investments, which could lead to stronger-than-expected revenue growth this quarter.

Supporting Evidence

PTC has a history of beating EPS estimates, suggesting operational improvements that may not be fully recognized.

The options market is pricing a significant move, indicating that investors expect more volatility and potential upside than currently reflected in stock prices.

Key Risk

If revenue growth exceeds expectations, it could challenge the current bearish sentiment and lead to a reevaluation of the stock's potential.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is pivotal as it will determine the market's confidence in PTC's growth trajectory and ability to manage costs effectively.

Bull Confirmed If

Achieving an EPS of $0.10 or better would confirm the bull case and indicate strong operational performance.

Bear Confirmed If

An EPS loss greater than -$0.50 would confirm the bear case and raise concerns about the company's financial health.

Pre-Earnings Positioning

Options Market

Implied Move

±23.83%

Historical Avg

±2.6%

Pricing rich

The options market is pricing in a significant potential move, indicating that investors expect volatility around the earnings report.

Options are pricing ±23.8% while PTCT has averaged ±2.6% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.5%

30d HV

56.4%

Calls (1K)P/C Ratio: 1.40Puts (0)

Edge

Insider Activity

Open-market trades by officers, directors, and 10%+ holders over the trailing 90 days.

Bought

$0.00

0 sh

0 insiders

Sold

$202,093.50

2,850 sh

1 insider

Net

$202,093.50

Net selling

Most Active Insiders· 1 open-market trade

CHIEF EXECUTIVE OFFICERKlein Matthew B.
$202,093.50

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If PTC beats expectations, history suggests the stock could see an average one-day move of +2.25%, confirming a positive outlook.

In-Line / Cautious

If results come in line with expectations, the stock may experience muted movement as investors await further clarity from management.

Miss

A miss could lead to a decline in stock price, with history suggesting an average one-day drop of +1.41% following such outcomes.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Updates on the company's product pipeline and any new therapies in development.
2Details on revenue growth and how it compares to previous quarters.
3Management's commentary on cost management and operational efficiency.
4Insights into market demand for PTC's products and therapies.
5Any guidance on future earnings or strategic initiatives.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Danaos Corporation

Company Snapshot

PTC Therapeutics, Inc. is a biotechnology company focused on developing innovative medicines for rare diseases....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and will show how well PTC is managing its costs and revenues.

N/A

Revenue Growth

Revenue growth is crucial for assessing the company's ability to expand its market presence and sustain operations.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

PTCT Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+101.20%

Avg Stock Reaction

-1.79%

Last Quarter Recap

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

If PTC can demonstrate strong revenue growth and continued improvement in EPS, it could signal a turnaround and attract more investor interest, potentially driving the stock higher.

Bear Case

If the company fails to meet revenue expectations or reports increased losses, it could lead to further declines in stock price, as investors may lose confidence in its growth prospects.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be this quarter, and how does it compare to previous quarters?

Given PTC's history of EPS surprises, this number will be critical in shaping investor sentiment and expectations.

What is the company's revenue growth compared to last quarter?

Revenue growth is essential for assessing the company's ability to sustain its operations and invest in future developments.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate PTC's ability to leverage its recent R&D investments, which could lead to stronger-than-expected revenue growth this quarter.

Supporting Evidence

PTC has a history of beating EPS estimates, suggesting operational improvements that may not be fully recognized.

The options market is pricing a significant move, indicating that investors expect more volatility and potential upside than currently reflected in stock prices.

Key Risk

If revenue growth exceeds expectations, it could challenge the current bearish sentiment and lead to a reevaluation of the stock's potential.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is pivotal as it will determine the market's confidence in PTC's growth trajectory and ability to manage costs effectively.

Bull Confirmed If

Achieving an EPS of $0.10 or better would confirm the bull case and indicate strong operational performance.

Bear Confirmed If

An EPS loss greater than -$0.50 would confirm the bear case and raise concerns about the company's financial health.

Pre-Earnings Positioning

Options Market

Implied Move

±23.83%

Historical Avg

±2.6%

Pricing rich

The options market is pricing in a significant potential move, indicating that investors expect volatility around the earnings report.

Options are pricing ±23.8% while PTCT has averaged ±2.6% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.5%

30d HV

56.4%

Calls (1K)P/C Ratio: 1.40Puts (0)

Edge

Insider Activity

Open-market trades by officers, directors, and 10%+ holders over the trailing 90 days.

Bought

$0.00

0 sh

0 insiders

Sold

$202,093.50

2,850 sh

1 insider

Net

$202,093.50

Net selling

Most Active Insiders· 1 open-market trade

CHIEF EXECUTIVE OFFICERKlein Matthew B.
$202,093.50

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If PTC beats expectations, history suggests the stock could see an average one-day move of +2.25%, confirming a positive outlook.

In-Line / Cautious

If results come in line with expectations, the stock may experience muted movement as investors await further clarity from management.

Miss

A miss could lead to a decline in stock price, with history suggesting an average one-day drop of +1.41% following such outcomes.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Updates on the company's product pipeline and any new therapies in development.
2Details on revenue growth and how it compares to previous quarters.
3Management's commentary on cost management and operational efficiency.
4Insights into market demand for PTC's products and therapies.
5Any guidance on future earnings or strategic initiatives.